
Katie Beth Hand, patient 9 in the Eledon trial, received an islet cell transplant in January 2026. She is now living a "functionally cured" life, but every 21 days she requires a transfusion of an immunosuppressant called Tegoprubart which stops her body from attacking the newly implanted islet cells. In this conversation, we get into how the trial works, what it feels like to stop taking insulin after years of type 1 diabetes, and the complicated emotions that come with this new normal. Learn about the RESET T1D study (sponsor) Learn about Omnipod 5 (sponsor)* Join the Diabetech Newsletter Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads Follow Katie Beth Hand: Instagram | Tik Tok DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Dexcom Exec Interview: G7 Fixes and the Future of G8

Why Schools are Failing Kids with Type 1 Diabetes

How To Exercise with T1D & Stay in Range

Stash: The Diabetes App for Supply Tracking & Travel
Free AI-powered recaps of Diabetech - Diabetes Tech, Research, News and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.